Groff Hemplex LLC has applied to the Drug Enforcement Administration to be registered as a bulk manufacturer of certain controlled substances. The company plans to use these substances for its own purposes and to sell them to approved research investigators. The public can submit comments or objections electronically by April 28, 2025, and also request a hearing on this application by the same date. This application process follows the regulations set by the DEA under 21 CFR 1301.33(a).
Simple Explanation
Groff Hemplex LLC wants permission from the government to make special kinds of medicines and sell them to scientists for research. People can tell the government what they think about this by April 28, 2025.